210 related articles for article (PubMed ID: 26170308)
1. Human anti-nucleolin recombinant immunoagent for cancer therapy.
Palmieri D; Richmond T; Piovan C; Sheetz T; Zanesi N; Troise F; James C; Wernicke D; Nyei F; Gordon TJ; Consiglio J; Salvatore F; Coppola V; Pichiorri F; De Lorenzo C; Croce CM
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9418-23. PubMed ID: 26170308
[TBL] [Abstract][Full Text] [Related]
2. A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy.
D'Avino C; Palmieri D; Braddom A; Zanesi N; James C; Cole S; Salvatore F; Croce CM; De Lorenzo C
Oncotarget; 2016 Dec; 7(52):87016-87030. PubMed ID: 27894092
[TBL] [Abstract][Full Text] [Related]
3. New perspectives of physiological and pathological functions of nucleolin (NCL).
Jia W; Yao Z; Zhao J; Guan Q; Gao L
Life Sci; 2017 Oct; 186():1-10. PubMed ID: 28751161
[TBL] [Abstract][Full Text] [Related]
4. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH
Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538
[TBL] [Abstract][Full Text] [Related]
5. The roles of nucleolin subcellular localization in cancer.
Berger CM; Gaume X; Bouvet P
Biochimie; 2015 Jun; 113():78-85. PubMed ID: 25866190
[TBL] [Abstract][Full Text] [Related]
6. Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy.
Brignole C; Bensa V; Fonseca NA; Del Zotto G; Bruno S; Cruz AF; Malaguti F; Carlini B; Morandi F; Calarco E; Perri P; Moura V; Emionite L; Cilli M; De Leonardis F; Tondo A; Amoroso L; Conte M; Garaventa A; Sementa AR; Corrias MV; Ponzoni M; Moreira JN; Pastorino F
J Exp Clin Cancer Res; 2021 Jun; 40(1):180. PubMed ID: 34078433
[TBL] [Abstract][Full Text] [Related]
7. Regulation of nucleolin expression by miR-194, miR-206, and HuR.
Bose S; Tholanikunnel TE; Reuben A; Tholanikunnel BG; Spicer EK
Mol Cell Biochem; 2016 Jun; 417(1-2):141-53. PubMed ID: 27221739
[TBL] [Abstract][Full Text] [Related]
8. [Downregulation of cell-surface-expressed nucleolin inhibits the growth of hepatocellular carcinoma cells in vitro].
Meng GZ; Xiao SJ; Zeng SE; Li YQ
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):23-7. PubMed ID: 21575459
[TBL] [Abstract][Full Text] [Related]
9. In silico study predicts a key role of RNA-binding domains 3 and 4 in nucleolin-miRNA interactions.
San A; Palmieri D; Saxena A; Singh S
Proteins; 2022 Nov; 90(11):1837-1850. PubMed ID: 35514080
[TBL] [Abstract][Full Text] [Related]
10. Nucleolin antisense oligodeoxynucleotides induce apoptosis and may be used as a potential drug for nasopharyngeal carcinoma therapy.
Wu CD; Chou HW; Kuo YS; Lu RM; Hwang YC; Wu HC; Lin CT
Oncol Rep; 2012 Jan; 27(1):94-100. PubMed ID: 21956494
[TBL] [Abstract][Full Text] [Related]
11. Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro.
Chen Y; Huang K; Li X; Lin X; Zhu Z; Wu Y
Cancer Immunol Immunother; 2010 Jun; 59(6):933-42. PubMed ID: 20224978
[TBL] [Abstract][Full Text] [Related]
12. In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.
Pichiorri F; Palmieri D; De Luca L; Consiglio J; You J; Rocci A; Talabere T; Piovan C; Lagana A; Cascione L; Guan J; Gasparini P; Balatti V; Nuovo G; Coppola V; Hofmeister CC; Marcucci G; Byrd JC; Volinia S; Shapiro CL; Freitas MA; Croce CM
J Exp Med; 2013 May; 210(5):951-68. PubMed ID: 23610125
[TBL] [Abstract][Full Text] [Related]
13. Roles of nucleolin. Focus on cancer and anti-cancer therapy.
Chen Z; Xu X
Saudi Med J; 2016 Dec; 37(12):1312-1318. PubMed ID: 27874146
[TBL] [Abstract][Full Text] [Related]
14. The antitumor efficacy of a novel adenovirus-mediated anti-p21Ras single chain fragment variable antibody on human cancers in vitro and in vivo.
Yang JL; Pan XY; Zhao WX; Hu QC; Ding F; Feng Q; Li GY; Luo Y
Int J Oncol; 2016 Mar; 48(3):1218-28. PubMed ID: 26780944
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA Profiling of Transgenic Mice with Myocardial Overexpression of Nucleolin.
Lyu QL; Jiang BM; Zhou B; Sun L; Tong ZY; Li YB; Tang YT; Sun H; Liu MD; Xiao XZ
Chin Med J (Engl); 2018 Feb; 131(3):339-346. PubMed ID: 29363650
[TBL] [Abstract][Full Text] [Related]
16. Cell surface nucleolin as a target for anti-cancer therapies.
Koutsioumpa M; Papadimitriou E
Recent Pat Anticancer Drug Discov; 2014 May; 9(2):137-52. PubMed ID: 24251811
[TBL] [Abstract][Full Text] [Related]
17. Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies.
Ten Haaf A; Pscherer S; Fries K; Barth S; Gattenlöhner S; Tur MK
Immunol Lett; 2015 Aug; 166(2):65-78. PubMed ID: 26045318
[TBL] [Abstract][Full Text] [Related]
18. Nucleolin Is a Functional Binding Protein for Salinomycin in Neuroblastoma Stem Cells.
Wang F; Zhou S; Qi D; Xiang SH; Wong ET; Wang X; Fonkem E; Hsieh TC; Yang J; Kirmani B; Shabb JB; Wu JM; Wu M; Huang JH; Yu WH; Wu E
J Am Chem Soc; 2019 Feb; 141(8):3613-3622. PubMed ID: 30689374
[TBL] [Abstract][Full Text] [Related]
19. AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
Cheng Y; Zhao G; Zhang S; Nigim F; Zhou G; Yu Z; Song Y; Chen Y; Li Y
PLoS One; 2016; 11(12):e0167094. PubMed ID: 27907160
[TBL] [Abstract][Full Text] [Related]
20. Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display.
Keller T; Kalt R; Raab I; Schachner H; Mayrhofer C; Kerjaschki D; Hantusch B
PLoS One; 2015; 10(5):e0127169. PubMed ID: 25993332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
